Science 37 adds to its industry-leading virtual trial capabilities in Europe, South America, and Asia-Pacific.    LOS ANGELES, July 28, 2020 — Science 37, the industry leader in decentralized clinical trials, today announced a series of global investments, including an expanded European, Latin American and Asian nurse and investigator network, staffing in key European countries, and an operational center of excellence in Slovakia. “By strengthening our global presence, we’re enabling our sponsors to execute more decentralized…

Executive role applies financial rigor to ensure profitable growth as the company continues to scale. LOS ANGELES, May 19, 2020 — Science 37, the industry leader in virtual clinical trials, announced today that Mike Zaranek has joined the company as its chief financial officer (CFO). He will oversee all aspects of finance, accounting, and strategic pricing as the company prepares for its next stage of growth. Zaranek joins Science 37 from IQVIA’s Contract Sales and…

The partnership combines artificial intelligence with comprehensive virtual trial services to bring novel insights to research. LOS ANGELES & NEW YORK, April 30, 2020 — Science 37, the industry leader in virtual clinical trials, and AiCure, a leading artificial intelligence (AI) and advanced data analytics company, have announced a collaboration to support and deliver enhanced technology for virtual trials. As the first endeavor for the new partnership, the two companies will use a virtual or…

The partnership addresses key concerns for clinical trial sponsors as they transition to virtual trials in light of the COVID-19 pandemic.  LOS ANGELES & COLUMBIA, Md., April 21, 2020 — Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite approvals on COVID-19–related virtual trials. The partnership will help companies continue clinical research during the pandemic by allowing them to make quick adjustments to…

Rapid-Start COVID-19 Studies Delivered through Science 37 and Innovo Partnership   The new partnership will help accelerate the start-up time for clinical trials related to the COVID-19 pandemic.   LOS ANGELES & WILMINGTON, N.C., April 2, 2020 — Science 37, the industry leader in decentralized clinical trials, has partnered with Innovo Research, the national leader in innovative site networks, on a rapid-start solution to accelerate COVID-19 research for vaccines, drugs, and diagnostics. Innovo will utilize…

The report explores approaches for sponsors to mitigate risks to patient safety and business continuity in clinical trials—both immediately and moving forward.   LOS ANGELES, March 12, 2020 — Science 37, the industry leader in decentralized clinical trials, today published a report examining key considerations for patient safety and business continuity in the clinical trial industry in light of the current COVID-19 pandemic.    The impact of COVID-19 is immense and well documented in the…

The fully integrated mobile enhancement provides a real-time window into trial operations    LOS ANGELES, February 18, 2020 — Science 37, the industry leader in decentralized clinical trials, has launched mobile electronic data capture (EDC) integration for its comprehensive trial platform. With this development, the Science 37 platform can deliver trial data directly into an EDC system—bypassing manual entry and enabling real-time visibility into a trial’s progress. The enhanced functionality will help to lower overall…

The fully integrated mobile enhancement provides a real-time window into trial operations  LOS ANGELES, February 18, 2020 — Science 37, the industry leader in decentralized clinical trials, has launched mobile electronic data capture (EDC) integration for its comprehensive trial platform. With this development, the Science 37 platform can deliver trial data directly into an EDC system—bypassing manual entry and enabling real-time visibility into a trial’s progress. The enhanced functionality will help to lower overall trial…

New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies  LOS ANGELES, January 14, 2020 — Science 37, the industry leader in decentralized clinical trials, recently announced that Jonathan Commons and Darcy Forman have joined the company as vice president of patient engagement and vice president of clinical operations, respectively. The additions help Science 37 extend its market-leading capabilities…